Avolta (AVOL) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
13 Feb, 2026Executive summary
Reported 2024 revenue of CHF 13.5 billion, with 8.9% growth at constant exchange rates and 6.3% organic growth; excluding Argentina, organic growth was 7.7%.
CORE EBITDA rose 12.2% year-over-year to CHF 1,267 million, with margin expanding by 40 basis points to 9.4%.
Equity Free Cash Flow reached CHF 425 million, up 32% year-over-year, with conversion improving by 490 basis points to 33.5%.
Shareholder value initiatives included a 43% higher dividend (CHF 1.00/share), a CHF 200 million share buyback, and cancellation of 6.1 million shares.
2025 started strong, with organic growth at 6% (7.7% adjusted for leap year effect) and YTD revenue growth of 9.5% through February.
Financial highlights
FY 2024 revenue reached CHF 13.5 billion, with organic growth of 6.3% and CER growth of 8.9%.
CORE EBITDA was CHF 1,267 million (margin 9.4%), up from CHF 1,130 million in 2023.
Net profit attributable to equity holders was CHF 386 million, a 25% increase year-over-year.
EFCF conversion improved to 33.5% from 28% in 2023.
Net debt to EBITDA reduced to 2.1x (1.9x excluding share buyback), the lowest in over a decade.
Outlook and guidance
Medium-term targets: 5–7% organic revenue growth, 20–40 basis points annual EBITDA margin expansion, and 100–150 basis points annual improvement in Equity Free Cash Flow conversion.
2025 expected to continue strong performance, with regional diversification mitigating risks.
CapEx guidance remains at 4% of turnover; further improvements in cash conversion expected.
Capital allocation policy focuses on growth investments, balance sheet efficiency, and progressive dividends.
2025 currency translation expected to be broadly neutral at current rates.
Latest events from Avolta
- Strong growth, margin gains, and cash returns supported higher dividends and new buybacks.AVOL
Q4 202511 Mar 2026 - Turnover up 11%, EBITDA margin at 9%, and net profit to equity holders up 46.7%.AVOL
H1 20242 Feb 2026 - Record revenue, margin expansion, and share cancellation highlight robust growth and outlook.AVOL
Q3 2024 TU17 Jan 2026 - 5%-7% organic growth, margin gains, and higher shareholder returns targeted mid-term.AVOL
CMD 202520 Nov 2025 - Q1 2025 saw 8.2% turnover growth, margin expansion, and strong EMEA/LatAm performance.AVOL
Q1 2025 TU18 Nov 2025 - Organic growth 5.7%, EBITDA margin 9.3%, EPS up 28.7%, and leverage at 2.15x.AVOL
H1 202516 Nov 2025 - Record EFCF, 10.2% margin, 5.4% organic growth, and 1.9x leverage highlight strong results.AVOL
Q3 2025 TU1 Nov 2025